Zeo ScientifiX delays July 31, 2026 10-Q filing

Zeo ScientifiX, Inc. has filed a Form 12b-25 to delay its July 31, 2026 Form 10-Q, citing undue hardship, and expects to file within the standard five-day extension window.

Rhea-AI Filing Summary

Zeo ScientifiX, Inc. (ZEOX) filed a Form 12b-25 to notify regulators of a late filing of its Quarterly Report on Form 10-Q for the quarter ended July 31, 2026. The company states that compiling, disseminating and reviewing the information required for the report could not be completed by September 14, 2026 without undue hardship and expense.

Zeo ScientifiX indicates that it expects to file the delayed Form 10-Q within the five-calendar-day extension period permitted for a late quarterly report.

Key Figures

Quarter end date: July 31, 2026 Original Form 10-Q due date: September 14, 2026 Extension period for quarterly report: 5 calendar days +1 more

4 metrics

Quarter end date July 31, 2026 Period covered by the delayed Form 10-Q

Original Form 10-Q due date September 14, 2026 Date by which the Form 10-Q could not be filed

Extension period for quarterly report 5 calendar days Maximum extension for a Form 10-Q under Form 12b-25

Signature date September 14, 2026 Date the notification of late filing was signed

Key Terms

Form 12b-25, Quarterly Report on Form 10-Q, undue hardship and expense, Section 13 or 15(d) of the Securities Exchange Act of 1934

4 terms

Form 12b-25 regulatory

"filed a Form 12b-25 to notify regulators of a late filing"

Form 12b-25 is a notice a publicly traded company files with the U.S. Securities and Exchange Commission when it cannot deliver a required periodic report (like a quarterly or annual financial report) on time. It explains the reason for the delay and gives the company a short, temporary window to finish the report without being marked as delinquent; investors watch it because late filings can signal accounting, operational, or control issues that may affect a company’s reliability and stock risk, much like a missed homework deadline can raise concerns about a student’s preparedness.

Quarterly Report on Form 10-Q regulatory

"information required to be presented in the Quarterly Report on Form 10-Q"

A quarterly report on Form 10-Q is a standardized financial filing public companies must submit to U.S. regulators every three months, summarizing recent financial results, cash flows, balance sheet changes, operations and material risks or legal developments. Investors treat it like a company report card that shows up-to-date facts rather than marketing copy, helping them track performance, spot trends, reassess risk and make buy or sell decisions.

undue hardship and expense financial

"could not be completed and filed by September 14, 2026, without undue hardship and expense"

Section 13 or 15(d) of the Securities Exchange Act of 1934 regulatory

"periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Zeo ScientifiX, Inc. (ZEOX) file a Form 12b-25?

Zeo ScientifiX filed Form 12b-25 because the information required for its Form 10-Q for the quarter ended July 31, 2026 could not be compiled, disseminated and reviewed in time to file by September 14, 2026 without undue hardship and expense.

Which filing by ZEOX is affected by the late filing notice?

The late filing notice relates to Zeo ScientifiX’s Quarterly Report on Form 10-Q for the quarter ended July 31, 2026.

When does Zeo ScientifiX expect to file the delayed Form 10-Q for ZEOX?

Zeo ScientifiX indicates that the delayed Form 10-Q will be filed within the five-calendar-day extension period allowed for late quarterly reports under Form 12b-25.

What reason does Zeo ScientifiX (ZEOX) give for not filing the Form 10-Q on time?

The company states that the compilation, dissemination and review of information required for the Form 10-Q for the quarter ended July 31, 2026, could not be completed and filed by September 14, 2026 without undue hardship and expense.

Who signed the Form 12b-25 for Zeo ScientifiX, Inc. (ZEOX)?

The notification was signed on September 14, 2026 by Ian Bothwell, who serves as Chief Executive Officer and Chief Financial Officer of Zeo ScientifiX, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 04:05 PM Accepted by SEC EDGAR 09/14/2026 - 04:05 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

SEC File Number:

000-55008

NOTIFICATION OF LATE FILING

(Check One): ☐ Form 10-K            ☐ Form 20-F         ☐ Form 11-K        ☒ Form 10-Q        ☐ Form 10-D
☐ Form N-SAR        ☐ Form N-CSR

For Period Ended: July 31, 2026

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

☐ Transition Report on Form N-SAR

For the Transition Period Ended: ________________________

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I – REGISTRANT INFORMATION

ZEO SCIENTIFIX, INC.

Full Name of Registrant

____________________________

Former Name if Applicable

3321 College Avenue, Suite 246

Address of Principal Executive Office (Street and Number)

Davie, Florida 33314

City, State and Zip Code

PART II – RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

	(a)	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III – NARRATIVE

State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.)

The compilation, dissemination and review of the information required to be presented in the Quarterly Report on Form 10-Q for the quarter ended July 31, 2026 could not be completed and filed by September 14, 2026, without undue hardship and expense to the registrant.

PART IV – OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Ian Bothwell		310		200-9741
(Name)		(Area Code)		(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

☒ Yes   ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

☐ Yes   ☒ No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

1

Zeo ScientifiX, Inc.

(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date: September 14, 2026	By:	/s/ Ian Bothwell
		Ian Bothwell,
		Chief Executive Officer and Chief Financial Officer

2